DSCAM-AS1 and endometrial cancer: As we observed both DSCAM-AS1 to be overexpressed in endometrial cancer tissue and growth inhibition of HEC-1B cells after its knockdown, we now examined transcriptome alterations and signaling pathways which might underlie these observations.